Skip to main content

Clover Health Investments Corp(CLOV-Q)
NASDAQ

Today's Change
Delayed Last Update
Day Low1.9550
Day High2.0300
Open:1.9700
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

TOP STORIES: Clover Health Investments Corp

Select a category then submit the form to load news
GlobeNewswire
UPDATED – Moving from Pledge to Production, Clover Health is Now Live on Kno2, Participating in Recently Announced Federal Interoperability Initiatives
Tipranks
Clover Health Highlights Transparency With Supplemental Earnings Q&A
StockStory
1 Cash-Heavy Stock with Impressive Fundamentals and 2 We Ignore
PRLB
GlobeNewswire
Clover Health Moves from Pledge to Production, Becomes The First Payer Live on a CMS Aligned Network
Tipranks
Analysts’ Top Healthcare Picks: Castle Biosciences (CSTL), Clover Health Investments (CLOV)
StockStory
Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know
CLOV
Motley Fool
Clover Health (CLOV) Q4 2025 Earnings Transcript
GlobeNewswire
Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance
StockStory
Clover Health (CLOV) To Report Earnings Tomorrow: Here Is What To Expect
CLOV
StockStory
1 Russell 2000 Stock to Keep an Eye On and 2 Facing Challenges
MATW
StockStory
2 Small-Cap Stocks Worth Investigating and 1 We Ignore
URBN
GlobeNewswire
Clover Health to Participate in Upcoming Leerink 2026 Global Healthcare Conference
StockStory
1 High-Flying Stock with Solid Fundamentals and 2 We Find Risky
FRPT
StockStory
1 Stock Under $10 to Target This Week and 2 Facing Headwinds
QRHC
GlobeNewswire
Clover Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
StockStory
Clover Health (CLOV): Buy, Sell, or Hold Post Q3 Earnings?
CLOV
Tipranks
Analysts Conflicted on These Healthcare Names: Clover Health Investments (CLOV) and Intellia Therapeutics (NTLA)
StockStory
Clover Health (CLOV) Stock Trades Up, Here Is Why
CLOV
Zacks Investment Research
CLOV Reports MA Membership Growth, Signals GAAP Profitability in 2026
CLOV Reports MA Membership Growth, Signals GAAP Profitability in 2026
Tipranks
Clover Health Projects 2026 Profitability as Membership Surges
StockStory
Clover Health (CLOV) Shares Skyrocket, What You Need To Know
CLOV
GlobeNewswire
Clover Health Announces 53% Growth in Medicare Advantage Membership During AEP, Increasing to 153,000 Members as of January 1, 2026; Expects First-Ever Full Year GAAP Net Income Profitability in 2026
GlobeNewswire
Counterpart Health 2025 Results: How Better Clinical Decisions at Scale Improve Outcomes, Quality, and Cost
StockStory
2 Cash-Heavy Stocks Worth Investigating and 1 Facing Challenges
PCTY
GlobeNewswire
Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference
Tipranks
Clover Health Unveils Counterpart Assistant Adoption
GlobeNewswire
From Hype to P&L: Hospitals Now Buying AI That Pays
StockStory
1 Russell 2000 Stock to Target This Week and 2 We Ignore
RUSHA
StockStory
1 Small-Cap Stock with Competitive Advantages and 2 Facing Headwinds
JAMF
StockStory
Integra LifeSciences, Evolent Health, Incyte, iRhythm, and Clover Health Stocks Trade Up, What You Need To Know
IART
StockStory
Clover Health, GoodRx, Moderna, UFP Technologies, and Masimo Shares Are Soaring, What You Need To Know
CLOV
GlobeNewswire
Clover Health to Participate in Upcoming 2025 Citi Global Healthcare Conference

Profile

Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.